Charles Homcy
InvestorFounderPartner at Third Rock Ventures · Board director at Faze Medicines · Board director at Pliant Therapeutics · Board director at Myokardia
San Francisco, California
Writes $100K – $5M checks · typically $1.5M
About
A physician with extensive experience building and leading biotech companies, focused on forming companies developing novel therapeutics. He has been a clinical professor at UCSF Medical School and an attending physician at the San Francisco VA Medical Center since 1997, and previously co-founded Portola Pharmaceuticals, serving as its president and CEO.
Invests in
Biotech
Board director at Faze Medicines
Intro paths
In turn, Charles can intro founders to Faze Medicines's investors below.
Faze Medicines's investors · 1
Board director at Pliant Therapeutics
Intro paths
In turn, Charles can intro founders to Pliant Therapeutics's investors below.
Pliant Therapeutics's investors · 3
Co-founders at Pliant Therapeutics
Board director at Myokardia
Intro paths
In turn, Charles can intro founders to Myokardia's investors below.
Deals · 3
Faze MedicinesBoard seat
via Third Rock Ventures · filed Dec 2020 · $81M raise
Pliant TherapeuticsBoard seat
via Third Rock Ventures · filed Jul 2018 · $62.1M raise
MyokardiaBoard seat
via Third Rock Ventures · filed Apr 2015 · $46M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Portola Pharmaceuticals
Sources: the firm's website · SEC Form D filings.
Colleagues at Third Rock Ventures
Network6
Investors connected to Charles in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Charles Homcy?
- A physician with extensive experience building and leading biotech companies, focused on forming companies developing novel therapeutics. He has been a clinical professor at UCSF Medical School and an attending physician at the San Francisco VA Medical Center since 1997, and previously co-founded Portola Pharmaceuticals, serving as its president and CEO.
- Where does Charles Homcy work?
- Charles Homcy is Partner at Third Rock Ventures and Board director at Faze Medicines and Board director at Pliant Therapeutics and Board director at Myokardia.
- What does Charles Homcy invest in?
- Charles Homcy invests in Biotech.
- What check size does Charles Homcy write?
- Charles Homcy typically writes checks of $100K – $5M.
- What boards does Charles Homcy sit on?
- Charles Homcy holds tracked board seats at Faze Medicines, Myokardia, Pliant Therapeutics.
- What companies has Charles Homcy invested in?
- Investments tracked here include Portola Pharmaceuticals.
- Does Charles Homcy lead rounds?
- Yes — Charles Homcy has led 1 tracked investment.